Jaguar Health JAGX Insider Ownership

NASDAQ JAGX
$2.63 -0.19 (-6.74%)
At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

198 Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.061%
■0% pp QoQ
Shares Held by Insiders
198
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
323.81K
323,814 shares
Direct Holdings
198
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
10
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Updated

Over the trailing 12 months, JAGX insiders made no open-market trades in the stock.

Form 4 Holdings

Insiders Holding JAGX

Insiders 10
Shares held 198
Of outstanding 0.061%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Lisa A Conte Ceo And President 56 0 56 28.1% 21 Jan, 2026
2 Pravin R Chaturvedi Chief Scientific Officer 23 0 23 11.5% 15 Dec, 2025
3 Jonathan S. Wolin Chief Of Staff, Cco Gc 23 0 23 11.5% 21 Jan, 2026
4 Carol R. Lizak Chief Financial Officer 23 0 23 11.4% 15 Dec, 2025
5 Steven R. King Chief Of Sustainable Supply 23 0 23 11.4% 21 Jan, 2026
6 John Micek Director 14 0 14 7.1% 15 Dec, 2025
7 Jonathan B. Siegel Director 14 0 14 7.1% 15 Dec, 2025
8 James J Bochnowski Director 12 0 12 6.2% 15 Dec, 2025
9 Anula Jayasuriya Director 11 0 11 5.7% 15 Dec, 2025
10 Gregory J Divis Director 0 0 0 0.0% 18 May, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

271 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
11 Dec, 2025 Jonathan S. Wolin Officer Acquired A 11,740 $0.00 $0 23 Direct
11 Dec, 2025 Steven R. King Officer Acquired A 11,740 $0.00 $0 23 Direct
11 Dec, 2025 Lisa A Conte Director, Officer Acquired A 28,592 $0.00 $0 56 Direct
11 Dec, 2025 Steven R. King Officer Acquired A 11,740 $0.00 $0 22 Direct
11 Dec, 2025 Jonathan S. Wolin Officer Acquired A 11,740 $0.00 $0 22 Direct
11 Dec, 2025 Lisa A Conte Director, Officer Acquired A 28,592 $0.00 $0 54 Direct
11 Dec, 2025 Anula Jayasuriya Director Acquired A 5,870 $0.00 $0 11 Direct
11 Dec, 2025 Jonathan B. Siegel Director Acquired A 7,377 $0.00 $0 14 Direct
11 Dec, 2025 John Micek Director Acquired A 7,377 $0.00 $0 14 Direct
11 Dec, 2025 James J Bochnowski Director Acquired A 6,363 $0.00 $0 12 Direct
11 Dec, 2025 Pravin R Chaturvedi Chief Scientific Officer Acquired A 11,740 $0.00 $0 23 Direct
11 Dec, 2025 Carol R. Lizak Chief Financial Officer Acquired A 11,740 $0.00 $0 23 Direct
11 Dec, 2025 Jonathan B. Siegel Director Acquired A 7,377 $0.00 $0 14 Direct
11 Dec, 2025 Anula Jayasuriya Director Acquired A 5,870 $0.00 $0 11 Direct
11 Dec, 2025 James J Bochnowski Director Acquired A 6,363 $0.00 $0 12 Direct
11 Dec, 2025 Pravin R Chaturvedi Chief Scientific Officer Acquired A 11,740 $0.00 $0 22 Direct
11 Dec, 2025 Carol R. Lizak Chief Financial Officer Acquired A 11,740 $0.00 $0 22 Direct
11 Dec, 2025 John Micek Director Acquired A 7,377 $0.00 $0 14 Direct
24 Jun, 2025 Lisa A Conte Ceo And President Disposed D 9,000 $26,250,000.00 $236.25Bn 0 Direct
24 Jun, 2025 James J Bochnowski Director Disposed D 27,002 $78,750,000.00 $2.13Tn 0 Indirect